Patents by Inventor Paolo Magri?

Paolo Magri? has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9820948
    Abstract: The present invention concerns a new composition based on pellets of lipoic acid in a lipophilic medium, if necessary combined with other active ingredients.
    Type: Grant
    Filed: October 23, 2008
    Date of Patent: November 21, 2017
    Assignee: Olon S.p.A.
    Inventors: Paolo Magri', Antonio Nardi, Annibale Salvi, Flavio Villani
  • Patent number: 9410169
    Abstract: The present invention relates to an enantioselective enzymatic process for the preparation of an optically active 3-hydroxypiperidinecarboxylic acid derivative.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: August 9, 2016
    Assignee: LABORATORIO CHIMICO INTERNAZIONALE S.P.A.
    Inventors: Giorgio Bertolini, Paolo Magri′
  • Publication number: 20150275249
    Abstract: The present invention relates to an enantioselective enzymatic process for the preparation of an optically active 3-hydroxypiperidinecarboxylic acid derivative.
    Type: Application
    Filed: June 18, 2012
    Publication date: October 1, 2015
    Applicant: LABORATORIO cHIMICO INTERNAZIONALE S.p. A.
    Inventors: Giorgio Bertolini, Paolo Magri'
  • Publication number: 20140197062
    Abstract: The invention refers to a new system for packaging pharmaceutical compositions comprising active principles that may be administered intravenously, in particular it concerns a system for packaging in bottles which makes it possible to ensure the complete transfer of the content of the bottle into the liquid for intravenous infusion and at the same time prevent any accidental contact with the active principle by the health-care personnel preparing said intravenous infusion, and a complete kit for intravenous administration.
    Type: Application
    Filed: February 12, 2014
    Publication date: July 17, 2014
    Applicant: INFA S.A.
    Inventors: Paolo Magri', Flavio Villani
  • Patent number: 8721616
    Abstract: The invention refers to a new system for packaging pharmaceutical compositions comprising active principles that may be administered intravenously, in particular it concerns a system for packaging in bottles which makes it possible to ensure the complete transfer of the content of the bottle into the liquid for intravenous infusion and at the same time prevent any accidental contact with the active principle by the health-care personnel preparing said intravenous infusion, and a complete kit for intravenous administration.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: May 13, 2014
    Assignee: Infa S.A.
    Inventors: Paolo Magri′, Flavio Villani
  • Patent number: 8722096
    Abstract: Lipoic acid pellets are described, obtained from inert cores externally coated with lipoic acid. The so obtained active cores are coated with a first layer of insulating polymeric material and then with a polymeric coat that is insoluble at the gastric pH. Pellet are then formulated pharmaceutically, for instance in jelly capsules or controlled release capsules or as oral suspensions, dispersible powders, sachets, etc.
    Type: Grant
    Filed: May 25, 2007
    Date of Patent: May 13, 2014
    Assignees: Aptalis Pharma Limited, Laboratorio Chimico Internazionale S.p.A.
    Inventors: Luigi Boltri, Flavio Fabiani, Luigi Mapelli, Annibale Salvi, Paolo Magri', Antonio Nardi, Flavio Villani
  • Patent number: 8182449
    Abstract: The invention relates to a kit for parenteral administration of drugs, particularly a kit for the infusion of those medicaments dissolved in solvents that extract toxic components from PVC, which is also suitable for the infusion of highly active medicaments, said kit ensuring a safe administration both for the patient and for healthcare staff.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: May 22, 2012
    Assignee: INFA, S.A.
    Inventors: Flavio Villani, Paolo Magri′
  • Publication number: 20110129442
    Abstract: The present invention concerns a new composition based on pellets of lipoic acid in a lipophilic medium, if necessary combined with other active ingredients.
    Type: Application
    Filed: October 23, 2008
    Publication date: June 2, 2011
    Inventors: Paolo Magri', Antonio Nardi, Annibale Salvi, Flavio Villani
  • Publication number: 20100030182
    Abstract: The invention refers to a new system for packaging pharmaceutical compositions comprising active principles that may be administered intravenously, in particular it concerns a system for packaging in bottles which makes it possible to ensure the complete transfer of the content of the bottle into the liquid for intravenous infusion and at the same time prevent any accidental contact with the active principle by the health-care personnel preparing said intravenous infusion, and a complete kit for intravenous administration.
    Type: Application
    Filed: September 28, 2007
    Publication date: February 4, 2010
    Inventors: Paolo Magri', Flavio Villani
  • Publication number: 20090264830
    Abstract: The invention relates to a kit for parenteral administration of drugs, particularly a kit for the infusion of those medicaments dissolved in solvents that extract toxic components from PVC, which is also suitable for the infusion of highly active medicaments, said kit ensuring a safe administration both for the patient and for healthcare staff.
    Type: Application
    Filed: September 29, 2006
    Publication date: October 22, 2009
    Applicant: INFA S.A.
    Inventors: Flavio Villani, Paolo Magri
  • Publication number: 20090117232
    Abstract: Lipoic acid pellets are described, obtained from inert cores externally coated with lipoic acid. The so obtained active cores are coated with a first layer of insulating polymeric material and then with a polymeric coat that is insoluble at the gastric pH. Pellet are then formulated pharmaceutically, for instance in jelly capsules or controlled release capsules or as oral suspensions, dispersible powders, sachets, etc.
    Type: Application
    Filed: May 25, 2007
    Publication date: May 7, 2009
    Applicants: EURAND PHARMACEUTICALS LIMITED, LABORATORIO CHIMICO INTERNAZIONALE S.P.A.
    Inventors: Luigi Boltri, Flavio Fabiani, Luigi Mapelli, Annibale Salvi, Paolo Magri', Antonio Nardi, Flavio Villani
  • Publication number: 20080274997
    Abstract: A fluid bed granulation process for manufacturing non-hygroscopic, stable granulates containing a water-soluble salt of S-adenosylmethionine is described. Said process comprises: a) the simultaneous, sequential or alternate dispersion of at least a solution of a water-soluble salt of SAMe (A) and of a solution of a coating agent (B), on a fluid bed granulation carrier (C) and b) the fluid bed granulation of the mixture. Granulates obtainable by said process and solid oral pharmaceutical forms obtainable by said granulates are disclosed.
    Type: Application
    Filed: July 10, 2008
    Publication date: November 6, 2008
    Applicant: CHEMISTRY AND HEALTH INTERNATIONAL BV
    Inventors: CARLO CANTABENE, PAOLO MAGRI, MICHELE MULLER
  • Publication number: 20060275363
    Abstract: A fluid bed granulation process for manufacturing non-hygroscopic, stable granulates containing a water-soluble salt of S-adenosylmethionine is described. Said process comprises: a) the simultaneous, sequential or alternate dispersion of at least a solution of a water-soluble salt of SAMe (A) and of a solution of a coating agent (B), on a fluid bed granulation carrier (C) and b) the fluid bed granulation of the mixture. Granulates obtainable by said process and solid oral pharmaceutical forms obtainable by said granulates are disclosed.
    Type: Application
    Filed: March 28, 2006
    Publication date: December 7, 2006
    Applicant: CHEMISTRY AND HEALTH INTERNATIONAL BV
    Inventors: Carlo Cantabene, Paolo Magri, Michele Muller